News

August 26, 2016 3:15 pm
Three important new reports are shedding light on how daratumumab works, reports IMF Chairman Dr. Brian Durie in his blog this week. “Our understanding of its benefits—when used alone and in combinations—is evolving rapidly.” But is treatment...
August 17, 2016 3:15 pm
Close to one hundred members of the International Myeloma Working Group (IMWG) gathered in Copenhagen from June 7th to 9th, just prior to the European Hematology Association (EHA) meeting, for the seventh annual IMWG Summit. This important and...
August 17, 2016 3:00 pm
Recognizing our responsibility to lead the way in addressing costs effectively, members of the International Myeloma Working Group (IMWG), the research arm of the IMF, launched a plan of action at a special session of the June 2016 annual meeting...
August 8, 2016 9:45 am
NINLARO™ is the first and only oral proteasome inhibitor approved to provide a new treatment option for adult patients living with multiple myeloma in Canada who have received at least one prior therapy

Pages